Skip to main content
PREDILIFE logo

PREDILIFE — Investor Relations & Filings

Ticker · ALPRE ISIN · FR0010169920 LEI · 9695006IK5NBKHQU9116 PA Human health and social work activities
Open in API
Filings indexed 150 across all filing types
Latest filing 2019-07-12 Declaration of Voting R…
Country FR France
Listing PA ALPRE

About PREDILIFE

https://www.predilife.com/en/

PREDILIFE specializes in predictive medicine, developing solutions to assess an individual's risk of developing major diseases. The company's approach integrates medical data, such as genetic testing and imaging, with artificial intelligence and mathematical models to create personalized risk profiles. Its primary offerings are predictive health check-ups, including a specialized test for assessing the 5-year risk of breast cancer (MammoRisk®) and a multi-condition check-up that evaluates the risk for several common cancers (lung, prostate, colorectal, melanoma) and cardiovascular disease. Based on these risk profiles, PREDILIFE provides personalized follow-up and preventive recommendations. The company offers its end-to-end solution, which includes remote consultations, to businesses, insurers, and healthcare professionals to facilitate wider access to preventive care.

Recent filings

Filing Released Lang Actions
Information mensuelle relative au nombre d'actions composant le capital social et du nombre total de droits de vote
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release ('Communiqué de presse') published on July 12, 2019, titled 'Information mensuelle relative au nombre d'actions composant le capital social et du nombre total de droits de vote' (Monthly information relating to the number of shares comprising the share capital and the total number of voting rights) as of June 30, 2019. This content specifically reports on the total number of shares and voting rights, which is a mandatory disclosure related to capital structure changes or ownership thresholds. This aligns closely with the definition of 'Share Issue/Capital Change' (SHA) or potentially 'Major Shareholding Notification' (MRQ) if it were about ownership changes crossing a threshold. However, since it is a routine monthly disclosure of the total share count and voting rights, it is a specific type of capital structure update. Given the options, 'Share Issue/Capital Change' (SHA) is the most appropriate fit as it deals directly with the composition of the capital and voting rights, which are fundamental aspects of the share structure. It is not a general earnings release (ER), an interim report (IR), or a general regulatory filing (RNS) because it fits a more specific category related to capital structure.
2019-07-12 French
Bilan semestriel du contrat de liquidité contracté avec TSAF - Tradition Securities and Futures
Capital/Financing Update Classification · 1% confidence The document is a press release ('Communiqué de presse') dated July 12, 2019, detailing the semi-annual balance sheet ('Bilan semestriel') of a liquidity contract ('contrat de liquidité') managed by TSAF as of June 30, 2019. This type of announcement, which reports on specific financial arrangements (like liquidity management or share transactions by a designated agent) outside of standard periodic financial reports (like 10-K or IR), often falls under general regulatory announcements or specific transaction reporting. Since the content focuses on the activity within a liquidity contract (which involves share trading/holding for market stability), it is closely related to insider/executive transactions or capital structure management. However, it is not a Director's Dealing (DIRS) as it concerns a third-party agent managing a contract, nor is it a standard dividend (DIV) or capital change (SHA). Given the nature of reporting on specific, non-standard financial activities via a press release, and lacking a more specific category, it fits best as a general Regulatory Filing (RNS). It is too detailed to be a simple Report Publication Announcement (RPA) as it contains the actual data, but RNS serves as the best fit for miscellaneous regulatory disclosures not covered elsewhere.
2019-07-12 French
Informations privilégiées / Autres communiqués
Capital/Financing Update Classification · 1% confidence The document is a press release ('Communiqué de presse') announcing that PREDILIFE successfully completed a capital increase ('augmentation de capital') via a private placement ('placement privé') for €1.350 million. This action involves the issuance of new ordinary shares and details the resulting changes in share capital and shareholder structure. This directly relates to fundraising, financing activities, and capital structure changes. Therefore, the most appropriate classification is Capital/Financing Update (CAP). It is not an Earnings Release (ER) or an Interim Report (IR) as it focuses purely on the financing transaction.
2019-07-05 French
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
Environmental & Social Information Classification · 1% confidence The document is a press release dated June 20, 2019, announcing that three companies (Predilife, Agendia, and OncoDNA) will jointly present a new care pathway for breast cancer at the 5th congress of the SFMPP (Société Française de Médecine Prédictive et Personnalisée). It details the event, the companies involved, and provides 'About Us' sections. This type of announcement, which is a communication about an upcoming event or presentation rather than a formal regulatory financial filing (like 10-K, IR, or ER), best fits the category for general corporate announcements or investor relations material. Since it is a press release detailing company activities and participation in a scientific congress, it is most closely aligned with Investor Presentation (IP) if it were a presentation, or more generally, a Regulatory Filing (RNS) as a catch-all for non-standard announcements, or potentially a general Corporate Governance/Information release. Given the context of presenting scientific/clinical updates at a specialized congress, it functions as an informational update for stakeholders. It is not a formal financial report, earnings release, or management discussion. The closest fit among the specific options for a non-financial, informational corporate communication that isn't a formal report announcement is often RNS, but since it details specific company activities and presentations, it shares characteristics with an Investor Presentation (IP) or a general corporate update. However, since it is a press release announcing participation and presentation topics, and not the presentation itself, RNS (Regulatory Filings/General Announcements) is the most appropriate fallback for this type of corporate news release that doesn't fit the specific financial or governance codes.
2019-06-20 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "Information mensuelle relative au nombre d'actions composant le capital social et du nombre total de droits de vote" (Monthly information relating to the number of shares comprising the share capital and the total number of voting rights). It explicitly states the number of shares and voting rights as of May 31, 2019, and cites French regulatory articles (AMF and Code de Commerce) requiring this disclosure. This type of regular disclosure regarding the total number of shares and voting rights is a specific regulatory requirement, often related to capital structure changes or major shareholdings. Given the options, this information most closely relates to changes in the capital structure or major shareholdings. Since it is a formal, periodic disclosure of the total share count, it fits best under 'Share Issue/Capital Change' (SHA) or potentially 'Major Shareholding Notification' (MRQ) if the context implies crossing a threshold, but the primary focus is the total count. However, the most direct fit for a formal announcement detailing the total number of shares and voting rights, which is a fundamental aspect of the capital structure, is 'Share Issue/Capital Change' (SHA), although it is a routine update rather than a new issue. Given the specific nature of reporting the total share count and voting rights, which is often mandated alongside capital changes, SHA is the most appropriate category among the choices provided, as it deals directly with the composition of the capital.
2019-06-11 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 1% confidence The document is titled "Information mensuelle relative au nombre d'actions composant le capital social et du nombre total de droits de vote" (Monthly information relating to the number of shares comprising the share capital and the total number of voting rights). It explicitly states the number of shares and voting rights as of April 30, 2019, referencing French regulatory articles (AMF and Code de Commerce). This type of regular disclosure regarding the total share count and voting power is most closely aligned with notifications about capital structure changes or major shareholding notifications, but the specific nature of reporting the total share count and voting rights monthly points directly to a specific regulatory disclosure requirement. Among the provided codes, 'SHA' (Share Issue/Capital Change) covers capital structure announcements, and 'MRQ' (Major Shareholding Notification) covers changes in ownership thresholds. However, the most precise fit for a mandatory monthly disclosure of the total share count and voting rights, which is a fundamental aspect of capital structure reporting, is often categorized under capital structure updates or specific regulatory filings. Given the options, this is a direct report on the current capital structure and voting rights, which is a form of capital change/structure update. Since it is a direct report of the capital structure figures, and not a general announcement of a future event, it fits best under 'SHA' (Share Issue/Capital Change) as it details the current state of the capital base, or potentially 'RNS' if it were a generic regulatory filing. However, the content is highly specific to the capital base. In many contexts, this specific monthly disclosure is treated as a capital structure update. Let's re-evaluate the definitions. It is not a dividend (DIV), not a director dealing (DIRS), and not a major shareholder crossing a threshold (MRQ), but a statement of the total capital. 'SHA' is for 'Share Issue/Capital Change'. This document reports the current state of the capital base. Given the highly specific nature of reporting the total number of shares and voting rights, this is a mandatory disclosure related to the company's capital structure. I will classify this as 'SHA' as it is a direct report on the composition of the share capital.
2019-05-14 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.